Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.45 AUD | +2.27% | -.--% | +30.43% |
Jun. 03 | Immutep, Merck Collaborate on Trial for Lung Cancer Therapy | MT |
Jun. 03 | Immutep, Merck Partner for Efti and Keytruda Combo in Lung Cancer Trial | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+30.43% | 357M | |
+44.97% | 56.65B | |
-7.30% | 39.44B | |
+39.19% | 39.03B | |
-11.17% | 26.86B | |
+12.23% | 26.75B | |
-21.69% | 19.03B | |
+1.33% | 12.28B | |
+24.09% | 12.26B | |
+27.37% | 12.04B |
- Stock Market
- Equities
- IMM Stock
- News Immutep Limited
- Immutep Validates Initial Efficacy of Immunotherapy Medication in Phase Two Cancer Trial